Last Updated: June 18, 2026

THYPINONE Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Thypinone, and when can generic versions of Thypinone launch?

Thypinone is a drug marketed by Abbott and is included in one NDA.

The generic ingredient in THYPINONE is protirelin. There are four drug master file entries for this compound. Additional details are available on the protirelin profile page.

AI Deep Research

Questions you can ask:

What is the 5 year forecast for THYPINONE?
What are the global sales for THYPINONE?
What is Average Wholesale Price for THYPINONE?

Summary for THYPINONE

US Patents:	0
Applicants:	1
NDAs:	1

US Patents and Regulatory Information for THYPINONE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Abbott	THYPINONE	protirelin	INJECTABLE;INJECTION	017638-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for THYPINONE

See the table below for patents covering THYPINONE around the world.

Subscribe to access the full database, or Start Trial
Country	Patent Number	Title	Estimated Expiration
Australia	2018870		⤷ Start Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.